Kilgour, Marisa K. http://orcid.org/0000-0002-6657-749X
MacPherson, Sarah
Zacharias, Lauren G.
LeBlanc, Jodi
Babinszky, Sindy
Kowalchuk, Gabrielle
Parks, Scott
Sheldon, Ryan D.
Jones, Russell G. http://orcid.org/0000-0003-2250-4675
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Hamilton, Phineas T. http://orcid.org/0000-0001-6993-8505
Watson, Peter H. http://orcid.org/0000-0002-1642-0638
Lum, Julian J. http://orcid.org/0000-0002-5624-3541
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-18-1-0264)
Gouvernement du Canada | Canadian Institutes of Health Research (MOP-142351, PJT-162279, MOP-142259)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA22044901)
Cancer Prevention and Research Institute of Texas (RP180778)
Article History
Received: 14 November 2021
Accepted: 25 May 2022
First Online: 19 August 2022
Competing interests
: R.J.D. is a member of the scientific advisory boards of Vida Ventures and Agios Pharmaceuticals and is a founder of Atavistik Biosciences.